Neuren Pharmaceuticals Limited
NURPF
Other OTC16.10
USD
- -
- -
Total Valuation
Neuren Pharmaceuticals Limited carries a market capitalization of 2.04B, placing it among publicly traded companies globally.
| Market Cap | 2.04B |
| Enterprise Value | N/A |
Stock Price Statistics
Neuren Pharmaceuticals Limited's stock has gained approximately 26.37363% over the past 52 weeks. The 50-day moving average sits at 14.35, while the 200-day moving average is 11.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | 26.37363% |
| 50-Day Moving Average | 14.35 |
| 200-Day Moving Average | 11.14 |
| Average Volume (20 Days) | N/A |
Stock Splits
Neuren Pharmaceuticals Limited's most recent stock split took place on November 21, 2017 with a 20:1 split ratio.
| Last Split Date | 11/21/2017 |
| Split Ratio | 20:1 |